Herbas VPB

Print
EN | LT
LT - Heterociklilaminai, kaip PI3K inhibitoriai
EN - HETEROCYCLYLAMINES AS PI3K INHIBITORS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/519 (2006.01)
A61P 35/00 (2006.01)
A61P 29/00 (2006.01)
A61P 27/00 (2006.01)
A61P 19/00 (2006.01)
A61P 1/00 (2006.01)
A61P 17/00 (2006.01)
European patent
(11) Number of the document 3513793
(13) Kind of document T
(96) European patent application number 18215449.2
Date of filing the European patent application 2012-08-31
(97) Date of publication of the European application 2019-07-24
(45) Date of publication and mention of the grant of the patent 2021-03-10
(46) Date of publication of the claims translation 2021-06-10
Priority applications
(30) Number Date Country code
201161530866 P 2011-09-02 US
201261594882 P 2012-02-03 US
201261677445 P 2012-07-30 US
Inventors
(72)
LI, Yun-Long, US
YAO, Wenqing, US
COMBS, Andrew, P., US
YUE, Eddy, W., US
MEI, Song, US
ZHU, Wenyu, US
GLENN, Joseph, US
MADUSKUIE, Thomas, P., Jr., US
SPARKS, Richard, B., US
DOUTY, Brent, US
HE, Chunhong, US
Grantee
(73) Incyte Holdings Corporation, 1801 Augustine Cut-Off, Wilmington, DE 19803, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Heterociklilaminai, kaip PI3K inhibitoriai
  HETEROCYCLYLAMINES AS PI3K INHIBITORS
Last renewal fee
Payment date Validity (years) Amount
2025-08-25 14 289.00 EUR
Next renewal fee
2026-08-31